SI1311284T1 - - Google Patents

Info

Publication number
SI1311284T1
SI1311284T1 SI200130310T SI200130310T SI1311284T1 SI 1311284 T1 SI1311284 T1 SI 1311284T1 SI 200130310 T SI200130310 T SI 200130310T SI 200130310 T SI200130310 T SI 200130310T SI 1311284 T1 SI1311284 T1 SI 1311284T1
Authority
SI
Slovenia
Application number
SI200130310T
Inventor
Christopher Barnes
Matthias Frech
Uwe Hofmann
Johannes Gleitz
Wolfgang Strittmatter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SI1311284T1 publication Critical patent/SI1311284T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
SI200130310T 2000-08-25 2001-08-23 SI1311284T1 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00118542 2000-08-25
EP01976139A EP1311284B1 (en) 2000-08-25 2001-08-23 Saratin for inhibiting platelet adhesion to collagen
PCT/EP2001/009746 WO2002015919A2 (en) 2000-08-25 2001-08-23 Saratin for inhibiting platelet adhesion to collagen

Publications (1)

Publication Number Publication Date
SI1311284T1 true SI1311284T1 (xx) 2005-08-31

Family

ID=8169664

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130310T SI1311284T1 (xx) 2000-08-25 2001-08-23

Country Status (27)

Country Link
US (2) US6881722B2 (xx)
EP (1) EP1311284B1 (xx)
JP (1) JP4988131B2 (xx)
KR (1) KR100794277B1 (xx)
CN (1) CN1224421C (xx)
AR (1) AR030492A1 (xx)
AT (1) ATE285246T1 (xx)
AU (2) AU2001295506B2 (xx)
BR (1) BR0113478A (xx)
CA (1) CA2419385C (xx)
CZ (1) CZ302353B6 (xx)
DE (1) DE60107962T2 (xx)
DK (1) DK1311284T3 (xx)
EC (1) ECSP034485A (xx)
ES (1) ES2234896T3 (xx)
HK (1) HK1059736A1 (xx)
HU (1) HU229367B1 (xx)
MX (1) MXPA03001604A (xx)
MY (1) MY128992A (xx)
NO (1) NO331326B1 (xx)
PT (1) PT1311284E (xx)
RU (1) RU2302880C2 (xx)
SI (1) SI1311284T1 (xx)
SK (1) SK287829B6 (xx)
UA (1) UA77402C2 (xx)
WO (1) WO2002015919A2 (xx)
ZA (1) ZA200302296B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287496B6 (sk) * 1999-03-18 2010-12-07 Merck Patent Gmbh Polypeptid z H. medicinalis, spôsob jeho prípravy a použitie, farmaceutický prostriedok, polynukleotid, expresný vektor, hostiteľská bunka, protilátka a jej použitie
KR20050092029A (ko) 2003-01-10 2005-09-16 아블린쓰 엔.브이. 폰 빌레브란트 인자(ｖＷＦ) 또는 콜라겐에 대한낙타과로부터의 재조합 ＶＨＨ 단일 도메인 항체
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
JP2009510105A (ja) * 2005-09-28 2009-03-12 バイオバスキュラー インコーポレーティッド 血小板および細胞の接着、細胞移動、および炎症を阻止するための方法および組成物
US20080069774A1 (en) * 2005-11-17 2008-03-20 Lance Liotta Proteomic antisense molecular shield and targeting
CN117229423B (zh) * 2023-11-10 2024-02-06 北京科技大学 一种用于结合胶原的多肽纳米材料及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947401A (en) * 1971-10-05 1976-03-30 Union Optics Corporation Hydrogels of unsaturated ester copolymers
US5705355A (en) 1984-03-27 1998-01-06 Transgene, S.A. Hirudin, pharmaceutical compositions comprising it and their use
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
IL86857A (en) * 1988-06-24 1994-04-12 Yissum Res Dev Co Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
US5304121A (en) * 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
CA2052486A1 (en) * 1990-10-09 1992-04-10 Thomas M. Connolly Protein for inhibiting collagen-stimulated platelet aggregation
GB9022040D0 (en) * 1990-10-10 1990-11-21 Biopharm Ltd Platelet adhesion inhibitor
US5179082A (en) * 1990-11-13 1993-01-12 Merck & Co., Inc. Method for blocking platelet adhesion to collagen
DE4136513A1 (de) 1991-11-06 1993-05-13 Basf Ag Neues thrombininhibitorisches protein aus raubwanzen
PL180752B1 (pl) * 1993-07-01 2001-04-30 Merck Patent Gmbh Sposób wytwarzania oczyszczonego białka
WO1995003795A1 (en) * 1993-07-29 1995-02-09 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
US5532287A (en) * 1994-05-04 1996-07-02 Ciba-Geigy Corporation Radiation cured drug release controlling membrane
US6246715B1 (en) * 1998-06-26 2001-06-12 Samsung Electronics Co., Ltd. Data transmitter and receiver of a DS-CDMA communication system
US5843172A (en) * 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
WO2000023459A1 (en) * 1998-10-16 2000-04-27 Immunex Corporation Inhibitors of platelet activation and recruitment
IT1304135B1 (it) * 1998-11-26 2001-03-07 Magneti Marelli Spa Metodo di controllo dell' iniezione e dell' accensione in un motoreendotermico ad iniezione diretta per accelerare il riscaldamento del
IL144460A0 (en) * 1999-02-19 2002-05-23 Zymogenetics Inc Inhibitors for use in hemostasis and immune function
SK287496B6 (sk) 1999-03-18 2010-12-07 Merck Patent Gmbh Polypeptid z H. medicinalis, spôsob jeho prípravy a použitie, farmaceutický prostriedok, polynukleotid, expresný vektor, hostiteľská bunka, protilátka a jej použitie

Also Published As

Publication number Publication date
RU2302880C2 (ru) 2007-07-20
WO2002015919A3 (en) 2002-05-30
BR0113478A (pt) 2003-07-15
SK287829B6 (sk) 2011-11-04
CN1449291A (zh) 2003-10-15
JP2004506690A (ja) 2004-03-04
MY128992A (en) 2007-03-30
US20050143305A1 (en) 2005-06-30
US7459438B2 (en) 2008-12-02
CA2419385C (en) 2011-05-10
KR100794277B1 (ko) 2008-01-11
HUP0303747A2 (hu) 2004-03-01
SK3132003A3 (en) 2003-08-05
NO331326B1 (no) 2011-11-28
AU9550601A (en) 2002-03-04
MXPA03001604A (es) 2003-06-04
AR030492A1 (es) 2003-08-20
CA2419385A1 (en) 2002-02-28
UA77402C2 (en) 2006-12-15
NO20030841L (no) 2003-02-24
DK1311284T3 (da) 2005-04-18
NO20030841D0 (no) 2003-02-24
CN1224421C (zh) 2005-10-26
KR20030034141A (ko) 2003-05-01
ATE285246T1 (de) 2005-01-15
JP4988131B2 (ja) 2012-08-01
DE60107962D1 (de) 2005-01-27
HUP0303747A3 (en) 2006-01-30
CZ302353B6 (cs) 2011-03-30
ZA200302296B (en) 2004-06-30
US20030190342A1 (en) 2003-10-09
WO2002015919A2 (en) 2002-02-28
AU2001295506B2 (en) 2007-02-15
ECSP034485A (es) 2003-03-31
PT1311284E (pt) 2005-05-31
EP1311284B1 (en) 2004-12-22
US6881722B2 (en) 2005-04-19
PL359246A1 (en) 2004-08-23
HK1059736A1 (en) 2004-07-16
HU229367B1 (en) 2013-11-28
ES2234896T3 (es) 2005-07-01
DE60107962T2 (de) 2005-12-15
EP1311284A2 (en) 2003-05-21
CZ2003720A3 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
BE2014C035I2 (xx)
BE2012C026I2 (xx)
BE2011C032I2 (xx)
BE2011C041I2 (xx)
BE2009C057I2 (xx)
AU2000236815A8 (xx)
BE2010C040I2 (xx)
AU2000236813A8 (xx)
DE60141744D1 (xx)
JP2001011737A5 (xx)
JP2004500177A5 (xx)
CH694022C1 (xx)
BY5768C1 (xx)
BRPI0003419A (xx)
BRPI0000763B8 (xx)
BR122012015772A2 (xx)
JP2001356180A5 (xx)
AU2000265180A8 (xx)
CN3135584S (xx)
CN3143796S (xx)
AU2000278563A8 (xx)
AU2000278560A8 (xx)
CN3149245S (xx)
AU2000266391A8 (xx)
CN3141410S (xx)